JFS Wealth Advisors’s iRadimed IRMD Stock Holding History

JFS Wealth Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,750	Closed	-$59K	–	1791
2021 Q3	$59K	Hold	1,750	–	–	0.01%	391
2021 Q2	$51K	Buy	+1,750	New	+$48.2K	0.01%	268
2016 Q4	–	Sell	-190,000	Closed	-$3.23M	–	466
2016 Q3	$3.23M	Hold	190,000	–	–	0.92%	30
2016 Q2	$4.13M	Sell	190,000 -15,000	-7%	-$270K	1.14%	19
2016 Q1	$3.93M	Buy	205,000 +5,000	+3%	+$95.7K	1.16%	22
2015 Q4	$5.61M	Buy	+200,000	New	+$5.65M	1.61%	14
2015 Q3	–	Sell	-4,200	Closed	-$98K	–	521
2015 Q2	$98K	Hold	4,200	–	–	0.05%	126
2015 Q1	$64K	Buy	4,200 +1,200	+40%	+$17.7K	0.03%	161
2014 Q4	$39K	Hold	3,000	–	–	0.01%	216
2014 Q3	$21K	Buy	+3,000	New	+$27.2K	﹤0.01%	256

Other funds holding IRMD

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

RCG

Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

JFS Wealth Advisors's IRMD Position: Q4 2021 in Review

JFS Wealth Advisors sold out of iRadimed (IRMD) in Q4 2021, closing a stake of 1,750 shares — an estimated $59K sold.

JFS Wealth Advisors first reported a position in IRMD in Q3 2014 and held it in 10 quarters. The position peaked at $5.61M in Q4 2015. 97 funds tracked by Wall St. Rank hold IRMD as of Q4 2021.

JFS Wealth Advisors reported no remaining iRadimed position as of Q4 2021 after selling out during the quarter.
JFS Wealth Advisors sold 1,750 iRadimed shares in Q4 2021, an estimated $59K.
JFS Wealth Advisors first reported a position in iRadimed in Q3 2014 and held it in 10 quarters.
JFS Wealth Advisors's iRadimed position peaked at $5.61M in Q4 2015.
97 funds tracked by Wall St. Rank held iRadimed as of Q4 2021.

Based on JFS Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.